A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

Trial Profile

A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

Phase of Trial: Phase III

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Cytomegalovirus immune globulin (Primary)
  • Indications Cytomegalovirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Actual initiation date (Apr 2012) added as reported by ClinicalTrials.gov.
    • 16 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top